PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in R/R High-Risk Myelodysplastic Syndrome & R/R Acute Myeloid Leukemia ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday ...

PureTech Systems Inc., a provider of geospatial AI-boosted video analytics for wide-area perimeter and border security, is proud to announce the integration of its patented PureActiv software with ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today ...

PureTech Health plc (NASDAQ:PRTC) stock is up on Monday, after the company announced results from ELEVATE IPF Phase 2b trial of deupirfenidone (LYT-100) for idiopathic pulmonary fibrosis (IPF). The ...

BELLE, W.Va.--(BUSINESS WIRE)--PureTech Scientific LLC (PureTech), a global leader in glycolic acid synthesis and technology, today announced the appointment of industry veteran Matthew Smith as Vice ...

PureTech Systems Inc. today announced the release of its new Interface Control Document (ICD). This essential document provides detailed information on the interfacing requirements necessary for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Known for producing companies ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and ...

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and ...